-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Capital Markets Maintains Buy on LifeMD, Raises Price Target to $10

Benzinga·03/12/2026 17:29:41
Listen to the news
Freedom Capital Markets analyst Ilya Zubkov maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $8 to $10.